Blood outgrowth endothelial cells alter remodeling of completely biological engineered grafts implanted into the sheep femoral artery

Journal of Cardiovascular Translational Research

Volumn 7, Issue 2, 2014, Pages 242-249

  Meier, Lee A ^a   Syedain, Zeeshan H ^a   Lahti, Matthew T ^b   Johnson, Sandra S ^a   Chen, Minna H ^a   Hebbel, Robert P ^b   Tranquillo, Robert T ^a  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Endothelial cells; Tissue engineering; Vascular graft

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COLLAGEN TYPE 4; ENOXAPARIN; FIBRONECTIN; LAMININ; VASCULAR ENDOTHELIAL CADHERIN;

ALLOGRAFT; ANASTOMOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY TRANSPLANTATION; ARTICLE; BASEMENT MEMBRANE; BIOCHEMISTRY; BIOENGINEERING; BIOMECHANICS; BLOOD VESSEL GRAFT; CELL GROWTH; CELL ISOLATION; CELL VIABILITY; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYOPRESERVATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEASIBILITY STUDY; FEMORAL ARTERY; GENETIC STABILITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP;

OVIS; OVIS ARIES;

ALLOGRAFTS; ANIMALS; BASEMENT MEMBRANE; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEASIBILITY STUDIES; FEMORAL ARTERY; FIBRIN; MODELS, ANIMAL; PROSTHESIS DESIGN; PULSATILE FLOW; SHEEP; STRESS, MECHANICAL; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84896394206     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9539-z     Document Type: Article

References (19)

1. Quint, C., Kondo, Y., Manson, R. J., Lawson, J. H., Dardik, A., & Niklason, L. E. (2011). Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci U S A, 108(22), 9214-9219. doi:10.1073/pnas.1019506108.
2. Tschoeke, B., Flanagan, T. C., Koch, S., Harwoko, M. S., Deichmann, T., Ella, V., Sachweh, J. S., Kellomaki, M., Gries, T., Schmitz-Rode, T., & Jockenhoevel, S. (2009). Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. Tissue Eng Part A, 15(8), 1909-1918. doi:10.1089/ten.tea.2008.0499.
3. Hashi, C. K., Derugin, N., Janairo, R. R., Lee, R., Schultz, D., Lotz, J., & Li, S. (2010). Antithrombogenic modification of small-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol, 30(8), 1621-1627. doi:10.1161/ATVBAHA.110.208348.
4. Hashi, C. K., Zhu, Y., Yang, G. Y., Young, W. L., Hsiao, B. S., Wang, K., Chu, B., & Li, S. (2007). Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A, 104(29), 11915-11920. doi:10.1073/pnas.0704581104. (Pubitemid 47185605)
5. Janairo, R. R., Henry, J. J., Lee, B. L., Hashi, C. K., Derugin, N., Lee, R., & Li, S. (2012). Heparin-modified small-diameter nanofibrous vascular grafts. IEEE transactions on nanobioscience, 11(1), 22-27. doi:10.1109/TNB.2012. 2188926.
6. Lin, Y., Weisdorf, D. J., Solovey, A., & Hebbel, R. P. (2000). Origins of circulating endothelial cells and endothelial outgrowth fromblood. J Clin Invest, 105(1), 71-77. doi:10.1172/JCI8071. (Pubitemid 30036389)
7. Glynn, J. J., & Hinds, M. T. (2013). Endothelial outgrowth cells: function and performance in vascular grafts. Tissue engineering Part B, Reviews. doi:10.1089/ten.TEB.2013.0285.
8. Stroncek, J. D., Grant, B. S., Brown, M. A., Povsic, T. J., Truskey, G. A., & Reichert, W. M. (2009). Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. Tissue engineering Part A, 15(11), 3473-3486. doi:10.1089/ten.TEA.2008.0673.
9. Wei, P., Milbauer, L. C., Enenstein, J., Nguyen, J., Pan, W., & Hebbel, R. P. (2011). Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer. BMC medicine, 9, 2. doi:10.1186/1741-7015-9-2.
10. Chang Milbauer, L., Wei, P., Enenstein, J., Jiang, A., Hillery, C. A., Scott, J. P., Nelson, S. C., Bodempudi, V., Topper, J. N., Yang, R. B., Hirsch, B., Pan, W., & Hebbel, R. P. (2008). Genetic endothelial systems biology of sickle stroke risk. Blood, 111(7), 3872-3879. doi: 10.1182/blood-2007-06-097188.
11. Syedain, Z. H., Meier, L. A., Bjork, J. W., Lee, A., & Tranquillo, R. T. (2011). Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials, 32(3), 714-722. doi:10.1016/j.biomaterials.2010.09. 019.
12. Syedain, Z. H., Meier, L. A., Lahti, M. T., Johnson, S. L., & Tranquillo, R. T. (submitted). Implantation of completely biological engineered arteries following decellularization into the sheep femoral artery. Tissue Eng Part A, (in press).
13. Bjork, J. W., Johnson, S. L., & Tranquillo, R. T. (2011). Ruthenium-catalyzed photo cross-linking of fibrin-based engineered tissue. Biomaterials, 32(10), 2479-2488. doi:10.1016/j.biomaterials.2010.12.010.
14. Michelson, A. D. (2008). P2Y12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol, 28(3), s33-s38. doi:10.1161/ATVBAHA.107.160689.
15. Turner, N. A., Hall, K. T., Ball, S. G., & Porter, K. E. (2007). Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis, 193(1), 36-43. doi:10.1016/j.atherosclerosis.2006.08.017. (Pubitemid 46776708)
16. Wang, C. H., Cherng, W. J., Yang, N. I., Kuo, L. T., Hsu, C. M., Yeh, H. I., Lan, Y. J., Yeh, C. H., & Stanford, W. L. (2008). Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol, 28(1), 54-60. doi:10.1161/ATVBAHA.107.147256.
17. Tsihlis, N. D., Oustwani, C. S., Vavra, A. K., Jiang, Q., Keefer, L. K., & Kibbe, M. R. (2011). Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10. Cell Biochem Biophys, 60(1-2), 89-97. doi:10.1007/s12013-011-9179-3.
18. Liang, Y., Jensen, T. W., Roy, E. J., Cha, C., Devolder, R. J., Kohman, R. E., Zhang, B. Z., Textor, K. B., Rund, L. A., Schook, L. B., Tong, Y. W., & Kong, H. (2011). Tuning the non-equilibrium state of a drug-encapsulated poly(ethylene glycol) hydrogel for stem and progenitor cell mobilization. Biomaterials, 32(7), 2004-2012. doi:10.1016/j.biomaterials.2010.11.021.
19. Kienstra, K. A., & Hirschi, K. K. (2012). Vascular progenitor cell mobilization. Methods Mol Biol, 904, 155-164. doi:10.1007/978-1-61779-943-3-13.